TNFRSF4 and neoplasm: In intratumoral CpG-treated lymphoma tumors, the murine OX40 PET signal correlated with treatment response before the occurrence of gross morphologic changes in the tumor and predicted therapeutic efficacy with greater accuracy than anatomic or blood-based biomarkers alone (20).